Edelweiss' research report on Zuari Agro Chemicals
PPL (40% JV) reported strong numbers despite tepid revenue growth (down 9%) with sharp improvement in EBITDA / mt to INR 3,680 versus INR 2,255 in Q2FY17 driven by lower input cost. This led to PAT catapulting 144% to INR 660mn. MCFL’s performance was broadly in line with estimate with revenue declining 5% and EBITDA and PAT jumping 3% and 40% to INR 620mn and INR 210mn, respectively.
Outlook
ZAC offers strong rerating potential driven by margin improvement, lower interest driven by reduction in working capital and better return ratios. Structural changes like DBT followed by ZAC’s dominant position are likely to trigger rerating. Hence, we raise target multiple to 15x FY19E EPS and raise TP to INR 758 and maintain ‘BUY’.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. ZUARI_AGRO_CHEMICALS_-_RESULT_UPDATE-OCT-17-EDEL
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!